<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35249138</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Common genetic basis of ALS patients and soccer players may contribute to disease risk.</ArticleTitle><Pagination><StartPage>4231</StartPage><EndPage>4238</EndPage><MedlinePgn>4231-4238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-05990-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the present study was to determine the prevalence of the ACSL A/G single nucleotide polymorphism among athletes and patients with amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disorder of motor neurons that leads to paralysis and death usually within 3-5&#xa0;years from onset. Previous epidemiological studies reported a higher risk of ALS among soccer players. The ACSL (long-chain-fatty-acid-CoA ligase 1) gene codes the long-chain fatty-acid-coenzyme A ligase family that plays a key role in lipid biosynthesis and fatty acid oxidation. The ACSL A/G polymorphism is associated with endurance trainability.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">One hundred and seventy-eight ALS patients, 172 athletes (60 soccer players, 112 middle- and long-distance runners), and 111 nonathletic controls participated in the study. Genomic DNA was extracted from blood or buccal cells according to the salting-out procedure. Genotypes were determined using the TaqMan allelic discrimination assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of the ACSL AA genotype was significantly higher among soccer players (35.0%) and ALS patients (39.3%) compared to runners (16.1%) and controls (18.0%). However, ALS GG carriers had a higher mortality rate.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We postulate that soccer players and ALS patients carry a common genetic predisposition that is related to impaired fatty acid utilization. Moreover, while the A allele might be associated with a genetic predisposition toward ALS, especially among soccer players, the G allele might be associated with disease severity. Further research is needed in order to explore the role of the ACSL rs6552828 polymorphism in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ben-Zaken</LastName><ForeName>Sigal</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8733-8159</Identifier><AffiliationInfo><Affiliation>The Academic College at Wingate, Wingate Institute, Netanya, Israel. sigalbz@wincol.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nefussy</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meckel</LastName><ForeName>Yoav</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Academic College at Wingate, Wingate Institute, Netanya, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliakim</LastName><ForeName>Alon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Department, Meir Medical Center, Kfar-Saba, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemet</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Department, Meir Medical Center, Kfar-Saba, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotkine</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorber</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeev</LastName><ForeName>Aviva</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Academic College at Wingate, Wingate Institute, Netanya, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drory</LastName><ForeName>Vivian E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.2.1.-</RegistryNumber><NameOfSubstance UI="D003066">Coenzyme A Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.2.1.3</RegistryNumber><NameOfSubstance UI="C583414">ACSL1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056352" MajorTopicYN="N">Athletes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003066" MajorTopicYN="N">Coenzyme A Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009061" MajorTopicYN="N">Mouth Mucosa</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012916" MajorTopicYN="Y">Soccer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACSL</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Genetic polymorphism</Keyword><Keyword MajorTopicYN="N">Soccer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>6</Day><Hour>20</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35249138</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-05990-4</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-05990-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955. https://doi.org/10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J-C, Torny F, Lacoste M et al (2005) Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2:202&#x2013;207. https://doi.org/10.1159/000089626</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A et al (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004&#x2013;1009. https://doi.org/10.1212/01.wnl.0000285080.70324.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F, Bruneteau G, Gordon PH et al (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:166&#x2013;171. https://doi.org/10.3109/17482960902822960</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus P, Fayemendy P, Nicol M et al (2018) Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol 25:97&#x2013;104. https://doi.org/10.1111/ene.13468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham A, Drory VE (2014) Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis. J Neurol 261:1133&#x2013;1138. https://doi.org/10.1007/s00415-014-7331-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7331-x</ArticleId><ArticleId IdType="pubmed">24699859</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, K&#xfc;hnlein P, Hendrich C et al (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613&#x2013;617. https://doi.org/10.1007/s00415-010-5805-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Dossena M et al (2009) ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler 10:205&#x2013;209. https://doi.org/10.1080/17482960902721634</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960902721634</ArticleId><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Benzi G, Dossena M et al (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472&#x2013;476. https://doi.org/10.1093/brain/awh373</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MHB, Seelen M, de Jong SW et al (2013) Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84:976&#x2013;981. https://doi.org/10.1136/jnnp-2012-304724</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304724</ArticleId><ArticleId IdType="pubmed">23418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N, Shih T, Stern Y et al (2002) Premorbid weight, body mass, and varsity athletics in ALS. Neurology 59:773&#x2013;775</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.773</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland D, Smith SA, Dolliff G et al (1996) Amyotrophic lateral sclerosis and occupational history. A pilot case-control study Arch Neurol 53:730&#x2013;733</Citation><ArticleIdList><ArticleId IdType="pubmed">8759978</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli S, Vanacore N (2005) Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol 20:237&#x2013;242</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-004-6879-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Taioli E (2007) All causes of mortality in male professional soccer players. Eur J Public Health 17:600&#x2013;604. https://doi.org/10.1093/eurpub/ckm035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckm035</ArticleId><ArticleId IdType="pubmed">17434875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A (2005) Mortality trends in ALS: an increasingly intricate puzzle. Lancet Neurol 4:453&#x2013;454. https://doi.org/10.1016/S1474-4422(05)70125-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70125-3</ArticleId><ArticleId IdType="pubmed">16033687</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel EL (2007) Football increases the risk for Lou Gehrig&#x2019;s disease, amyotrophic lateral sclerosis. Percept Mot Skills 104:1251&#x2013;1254</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.104.4.1251-1254</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Rooney JPK, D&#x2019;Ovidio F et al (2018) Multicentre, cross-cultural, population-based, case&#x2013;control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 89:797&#x2013;803. https://doi.org/10.1136/jnnp-2017-317724</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317724</ArticleId><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotkine M, Friedlander Y, Hochner H (2014) Triathletes are over-represented in a population of patients with ALS. Amyotroph Lateral Scler Front Degener 15:534&#x2013;536. https://doi.org/10.3109/21678421.2014.932383</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.932383</ArticleId></ArticleIdList></Reference><Reference><Citation>Longstreth WT, McGuire V, Koepsell TD et al (1998) Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 55:201&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.55.2.201</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti M, Pontieri FE, Conti F et al (2005) Amyotrophic lateral sclerosis and sports: a case-control study. Eur J Neurol 12:223&#x2013;225. https://doi.org/10.1111/j.1468-1331.2004.00978.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2004.00978.x</ArticleId><ArticleId IdType="pubmed">15693813</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, Kalmijn S, Groeneveld GJ et al (2005) Physical activity and the association with sporadic ALS. Neurology 64:241&#x2013;245. https://doi.org/10.1212/01.WNL.0000149513.82332.5C</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000149513.82332.5C</ArticleId><ArticleId IdType="pubmed">15668420</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E (2013) Are professional soccer players at higher risk for ALS? Amyotroph Lateral Scler Front Degener 14:501&#x2013;506. https://doi.org/10.3109/21678421.2013.809764</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.809764</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, McDermott CJ, Shaw PJ (2009) Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler 10:191&#x2013;204. https://doi.org/10.1080/17482960802549739</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802549739</ArticleId><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F et al (2015) Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol 7:181&#x2013;193. https://doi.org/10.2147/CLEP.S37505</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId><ArticleId IdType="pmc">4334292</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Al Khleifat A, Al-Chalabi A (2017) What causes amyotrophic lateral sclerosis? F1000Research 6:371</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10476.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray MS (2000) Genomics, genes, and environmental interaction: the role of exercise. J Appl Physiol 88:788&#x2013;792</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2000.88.2.788</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray MS, Hagberg JM, P&#xe9;russe L et al (2009) The human gene map for performance and health-related fitness phenotypes: the 2006&#x2013;2007 update. Med Sci Sports Exerc 41:35&#x2013;73</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0b013e3181844179</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly T, Gilbourne D (2003) Science and football: a review of applied research in the football codes. J Sports Sci 21:693&#x2013;705. https://doi.org/10.1080/0264041031000102105</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0264041031000102105</ArticleId><ArticleId IdType="pubmed">14579867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangsbo J (1994) The physiology of soccer&#x2013;with special reference to intense intermittent exercise. Acta Physiol Scand Suppl 619:1&#x2013;155</Citation><ArticleIdList><ArticleId IdType="pubmed">8059610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlin DL, Wenger HA (2001) The relationship between aerobic fitness and recovery from high intensity intermittent exercise. Sport Med 31:1&#x2013;11. https://doi.org/10.2165/00007256-200131010-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00007256-200131010-00001</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsom PD, Gaitanos GC, Ekblom B, Sj&#xf6;din B (1994) Reduced oxygen availability during high intensity intermittent exercise impairs performance. Acta Physiol Scand 152:279&#x2013;285. https://doi.org/10.1111/j.1748-1716.1994.tb09807.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.1994.tb09807.x</ArticleId><ArticleId IdType="pubmed">7872005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard C, Sarzynski MA, Rice TK et al (2011) Genomic predictors of the maximal O<sub>2</sub> uptake response to standardized exercise training programs. J Appl Physiol 110:1160&#x2013;1170. https://doi.org/10.1152/japplphysiol.00973.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00973.2010</ArticleId><ArticleId IdType="pubmed">21183627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampinini E, Coutts AJ, Castagna C et al (2007) Variation in top level soccer match performance. Int J Sports Med 28:1018&#x2013;1024. https://doi.org/10.1055/s-2007-965158</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-965158</ArticleId><ArticleId IdType="pubmed">17497575</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf8;len T, Chamari K, Castagna C, Wisl&#xf8;ff U (2005) Physiology of soccer: an update. Sports Med 35:501&#x2013;536. https://doi.org/10.2165/00007256-200535060-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00007256-200535060-00004</ArticleId><ArticleId IdType="pubmed">15974635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessi MS, Zarrouk N, Filetti C et al (2016) Physical and anthropometric changes during pre- and in-season in professional soccer players. J Sports Med Phys Fitness 56:1163&#x2013;1170</Citation><ArticleIdList><ArticleId IdType="pubmed">26364664</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckel Y, Doron O, Eliakim E, Eliakim A (2018) Seasonal variations in physical fitness and performance indices of elite soccer players. Sport (Basel, Switzerland) 6:14. https://doi.org/10.3390/sports6010014</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/sports6010014</ArticleId></ArticleIdList></Reference><Reference><Citation>Impellizzeri FM, Marcora SM, Castagna C et al (2006) Physiological and performance effects of generic versus specific aerobic training in soccer players. Int J Sports Med 27:483&#x2013;492. https://doi.org/10.1055/s-2005-865839</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2005-865839</ArticleId><ArticleId IdType="pubmed">16767613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall AM, Smith AJ, Bernlohr DA (2003) Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 278:43008&#x2013;43013. https://doi.org/10.1074/jbc.M306575200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M306575200</ArticleId><ArticleId IdType="pubmed">12937175</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashek DG, Li LO, Coleman RA (2006) Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J Lipid Res 47:2004&#x2013;2010. https://doi.org/10.1194/jlr.M600150-JLR200</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M600150-JLR200</ArticleId><ArticleId IdType="pubmed">16772660</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman RA, Lewin TM, Muoio DM (2000) Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu Rev Nutr 20:77&#x2013;103. https://doi.org/10.1146/annurev.nutr.20.1.77</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nutr.20.1.77</ArticleId><ArticleId IdType="pubmed">10940327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak H-B, Woodlief TL, Green TD, et al (2019) Overexpression of long-chain acyl-coa synthetase 5 increases fatty acid oxidation and free radical formation while attenuating insulin signaling in primary human skeletal myotubes. Int J Environ Res Public Health 16: https://doi.org/10.3390/ijerph16071157</Citation></Reference><Reference><Citation>Ellis RJ (2011) The role of long-chain acyl-coenzyme a synthetase 1 (ACSL-1) in lipid metabolism in human skeletal muscle primary myotubes</Citation></Reference><Reference><Citation>Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST (2018) Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front Mol Neurosci 11:10. https://doi.org/10.3389/fnmol.2018.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00010</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId><ArticleId IdType="pmc">5787076</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L (2018) Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 135:489&#x2013;509. https://doi.org/10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId><ArticleId IdType="pmc">5978930</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>